Genovare Peptides | Retatrutide | Triple Receptor Agonist — 30mg/3ml Pre-Sterilised Injection Pen

What It Is

Retatrutide is an advanced, next-generation peptide that simultaneously activates three key metabolic receptors — GLP-1, GIP, and glucagon. This triple-receptor mechanism sets it apart from earlier compounds, offering a broader and more comprehensive approach to metabolic health. Clinical research has highlighted its potential to support significant weight reduction, improve blood sugar regulation, and positively influence cholesterol levels and cardiovascular risk markers, making it one of the most talked-about developments in metabolic and obesity medicine today.

How It Is Used

Genovare Pharma's Retatrutide is delivered via a pre-sterilised injection pen, providing 30mg of the peptide in a 3ml subcutaneous formulation. Each pack contains one pen and three needles, intended for subcutaneous injection only. Like all Genovare Pharma formulations, it is verified at 99% purity by HPLC, ensuring accuracy, consistency, and safety with every dose.